Sector Update: Healthcare Higher Pre-Market; ImmunoGen Spikes 7% on Earnings

By
A A A

Healthcare stocks:

JNJ: flat

PFE: flat

ABT: flat

MRK: flat

AMGN: flat

Healthcare shares are flat in pre-market trade.

In healthcare stocks news, ImmunoGen, Inc. ( IMGN ) is up 7.3% in pre-market after it earlier reported a Q1 loss of $0.13 per share, ex one-time items, compared with the prior-year period's $0.30 loss per share. Revenues were $17.2 million, up from million in the same quarter last year.

Revenues for the quarter include $13.2 million in license and milestone fees, compared to $0.9 million in the comparable quarter a year ago. Analysts polled by Capital IQ were expecting a loss of $0.22 per share on revenues of $12.55 million.

And, BioMarin Pharmaceutical Inc. ( BMRN ) in yesterday's after-hours reported a Q3 GAAP loss of $0.38 per diluted share, compared to GAAP net loss of $0.04 per share for the comparable quarter of 2012. Analysts polled by Capital IQ estimated a GAAP and non-GAAP loss of $0.30 per share.

Revenues of $134.3 fell short of CIQ consensus for $139.8 million, but were higher than revenues of $126.3 million in the prior year period.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: BMRN , IMGN

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

183,639,073
  • $42.32 ▲ 3.85%
82,623,623
  • $15.99 ▼ 22.79%
39,547,942
  • $119 ▲ 1.19%
32,107,751
  • $77.62 ▲ 2.63%
29,684,848
  • $10.60 ▲ 2.02%
27,615,309
  • $24.03 ▲ 0.38%
26,917,669
  • $31.10 ▲ 2.07%
26,464,306
  • $47.75 ▲ 0.59%
As of 11/26/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com